EquityBulls

Latest News

Keywords Selected: INE044A01036

Stock Report

Sun Pharma Acquires Uractiv™ Portfolio from Fiterman Pharma in Romania
Sun Pharma to launch Brillo®, a first-in-class oral lipid-lowering drug in India
Sun Pharma announces US FDA Approval for Generic Mesalamine Extended Release Capsules
Sun Pharmaceutical Industries gets 10 observations from US FDA for Halol facility
Sun Pharma to introduce its version of Vortioxetine in India under an exclusive patent license from Lundbeck
Sun Pharma Presents Phase 3 Data for WINLEVI® (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting
Taro to acquire Alchemee from Galderma
Sun Pharmaceutical Industries Ltd declares interim dividend of Rs. 7
Sun Pharma launches solution for dry eye treatment with NCELL™ technology in Canada
Sun Pharma receives DCGI approval for Molxvir® in India
Sun Pharma announces US FDA Approval for Generic Amphotericin B Liposome Injection
Sun Pharma arm DUSA to get $22.5 mn from Biofrontera for settlement of litigation
Sun Pharma geared to introduce Molnupiravir, licensed from MSD and Ridgeback, under the brand name Molxvir® in India
Sun Pharma announces availability of WINLEVI® (clascoterone) cream 1% in the U.S. for Topical Treatment of Acne Vulgaris
Sun Pharma's PrILUMYA™ now available to help Canadians living with moderate-tosevere plaque psoriasis